Wim Van Biesen
Considerations on equity in management of end-stage kidney disease in low- and middle-income countries
Van Biesen, Wim; Jha, Vivekanand; Abu-Alfa, Ali K.; Andreoli, Sharon P.; Ashuntantang, Gloria; Bernieh, Bassam; Brown, Edwina; Chen, Yuqing; Coppo, Rosanna; Couchoud, Cecile; Cullis, Brett; Douthat, Walter; Eke, Felicia U.; Hemmelgarn, Brenda; Hou, Fan Fan; Levin, Nathan W.; Luyckx, Valerie A.; Morton, Rachael L.; Moosa, Mohammed Rafique; Murtagh, Fliss E.M.; Richards, Marie; Rondeau, Eric; Schneditz, Daniel; Shah, Kamal D.; Tesar, Vladimir; Yeates, Karen; Garcia Garcia, Guillermo
Ali K. Abu-Alfa
Sharon P. Andreoli
Felicia U. Eke
Fan Fan Hou
Nathan W. Levin
Valerie A. Luyckx
Rachael L. Morton
Mohammed Rafique Moosa
Fliss E.M. Murtagh
Kamal D. Shah
Guillermo Garcia Garcia
Professor Fliss Murtagh F.Murtagh@hull.ac.uk
Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.
|Journal Article Type||Article|
|Journal||Kidney International Supplements|
|Peer Reviewed||Peer Reviewed|
|APA6 Citation||Van Biesen, W., Jha, V., Abu-Alfa, A. K., Andreoli, S. P., Ashuntantang, G., Bernieh, B., …Garcia Garcia, G. (2020). Considerations on equity in management of end-stage kidney disease in low- and middle-income countries. Kidney International Supplements, 10(1), e63-e71. https://doi.org/10.1016/j.kisu.2019.11.004|
|Keywords||Nephrology; end-stage kidney disease; equity; ethical framework; kidney replacement therapy; reimbursement; social justice|
This file is under embargo due to copyright reasons.
Contact F.Murtagh@hull.ac.uk to request a copy for personal use.